SAN FRANCISCO – What is the prognosis for the near and long term for life sciences in China? Representatives from venture capital (VC) groups tackled that question, with answers ranging from "tempered enthusiasm" to "pessimistic," at least for the next 18 months. They made those responses during the second annual China Showcase, held in conjunction with the Biotech Showcase this week.